Safety Concerns Hit Bluebird Sickle Cell Trial, Again

 
• By Alaric DeArment
  
Sickle cell anemia, 3D illustration showing blood vessel with normal and deformated crescent-like red blood cells
The FDA placed a partial hold on bluebird bio's clinical program for lovo-cel in sickle cell disease • Source: Shutterstock

More from Gene Therapies

More from Advanced Therapies